At Pittcon 2013, Water Corp. announced improvement to chromatography systems and software.
At Pittcon 2013 in Philadelphia, Waters Corp. announced improvement to chromatography systems and software.
The company reported enhancements to the Waters Alliance HPLC system that will maintain key Alliance performance specifications and control algorithms to ensure that analysts can replicate their existing methods. The system features updated electronics and user interface. The updated systems can be used with Waters eXtended Performance [XP], 2.5 μm columns.
The company also announced an expansion of its laboratory informatics offerings, with the addition of Paradigm Scientific Search Software, which allows users to perform object-based searches across both structured and unstructured data and across different data platforms.
Mobile access and new laboratory analytics enhancements were added to Empower 3 chromatography data software.
Quality Control Reference Materials (QCRMs) and Certified Containers for Waters instruments were added to the Analytical Standards and Reagents product group.
Another technology introduction is the Waters ACQUITY Advanced Polymer Chromatography (APC) System, the company says, defines a new category of chromatographic polymer analysis, yielding improved molecular weight information about polymeric species, faster than ever before.
Waters Corp. announced updates to the Alliance HPLC system and Empower 3 chromatography data software, and introduced search software and reference materials.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.